Clinical Trial Results: Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neoadjuvant bevacizumab with fluorouracil, leucovorin, and oxaliplatin before surgery in stage II-III rectal cancer was terminated; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• FLUOROURACIL (Fluorouracil)
• Leucovorin calcium (calcium folinate)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: University of Southern California | Conditions: Mucinous Adenocarcinoma of the Rectum, Signet Ring Adenocarcinoma of the Rectum | Phase 2 | Status: TERMINATED | Results posted: 2026-07-01